Table 1.
Patient characteristics.
| Characteristic | n = 361 | % |
|---|---|---|
| Median age (range) | 68 (21–87) | |
| Gender | ||
| Male | 296 | 82 |
| Female | 65 | 18 |
| Performance status | ||
| 0 | 77 | 21 |
| 1 | 225 | 62 |
| 2 | 60 | 17 |
| Child-Pugh score | ||
| 5 | 270 | 75 |
| 6 | 91 | 25 |
| Chronic liver disease | ||
| Yes | 273 | 76 |
| No | 88 | 24 |
| Aetiology of chronic liver disease | ||
| HCV | 71 | 20 |
| HBV | 33 | 9 |
| Alcohol | 88 | 24 |
| NASH/NAFLD | 72 | 20 |
| Other | 36 | 10 |
| Unknown | 18 | 5 |
| Cirrhosis | ||
| Yes | 240 | 66 |
| No | 120 | 33 |
| Unknown | 1 | 0.3 |
| Prior treatment | ||
| None | 207 | 57 |
| TACE/TAE | 122 | 34 |
| Surgery | 37 | 10 |
| Ablation, | 20 | 6 |
| Baseline AFP | ||
| <400 ng/mL | 222 | 61 |
| ≥400 ng/mL | 133 | 37 |
HCV hepatitis C virus, HBV hepatitis B virus, NASH non-alcoholic steatohepatitis, NAFLD non-alcoholic fatty liver disease, TAE transarterial embolisation, TACE transarterial chemoembolisation, AFP alpha-fetoprotein.